• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

August 9, 2024

Research Demonstrates Asthma-Related Emergency Room Visits Increase During Peak Pollen Season

Author(s):

Gillian McGovern, Associate Editor

A number of asthma-related emergency room visits are a result of viruses, but certain airborne pollens—notably Cupressaceae and tree pollens—are also contributors.

Pollen from tree -- Image credit: AdobeTim82 | stock.adobe.com

Image credit: AdobeTim82 | stock.adobe.com

New research published in Environmental Research shows how many emergency department (ED) visits relating to asthma are a result of pollen in metropolitan areas, emphasizing the significance of understanding local plants and a need for developing science-based pollen forecasts. These forecasts suggest the authors can preemptively alert individuals who are susceptible to these allergens should take allergy medication before leaving their house or encourage them to consider staying indoors.1

For this study, the investigators quantified the effects of regionally important Cupressaceae pollen, tree pollen, other pollen types, rhinovirus, seasonal coronavirus, respiratory syncytial virus, and influenza on asthma-related ED visits for people who live within or near 8 pollen monitoring stations in Texas. Additionally, the researchers chose cities near Central Texas because a particular species of tree called the Ashe juniper—one of the most important allergenic pollen-producing trees—is prevalent.1,2

Additionally, to determine which asthma emergencies may have been a result of pollen—as opposed to viruses or other causes—the researchers collected data from the Texas Department of State Health Services, and analyzed nearly 175,000 asthma-related ED visits between 2015 and 2020. Notably, visits from patients who lived within 15 miles from 1 of 8 pollen monitoring stations where airborne pollen concentrations are measured were included in the analysis. Age-stratified Poisson regression analyses were used to quantify the effects of allergenic pollen and viruses on asthma-related ED visits.1,2

According to the study findings, children under the age of 5 years had high asthma-related ED visits, with about 24.1 visits per 1 million person-days. These visits, however, were primarily (51.2%) attributed to viruses. School-aged children also demonstrated high rates (20.7 visits/1 million person-days), which were also attributed to viruses (57.0%), as well as tree pollen (2.8%) and Cupressaceae pollen (0.7%). As for adults, this age group demonstrated lower rates of ED visits (8.1 visits/1 million person-days), of which approximately 25.4% were attributed to viruses, 2.3% to tree pollen, and 0.8% Cupressaceae pollen.2

“Even though the percent of asthma-related ED visits associated with pollen overall was only a few percent on an annual basis, at certain times of year when particular types of pollen were spiking, we sometimes saw up to almost 20% of visits were due to pollen,” said first study author Daniel Katz, PhD, assistant professor, School of Integrative Plant Science Soil and Crop Sciences Section, Cornell University, in a news release. “Sometimes the timing of when viruses were prevalent changed, and sometimes the timing of when pollen was in the air changed. So, because of this natural variability, we were able to better untangle what was contributing to these asthma-related ED visits.”1

Although viruses contributed to asthma-related ED visits, airborne pollen continues to make up a meaningful portion of visits during the peak pollen season. This risk, according to the investigators, can vary both over time and space because of differences within a plant’s composition. For example, they note that during peak Cupressaceae season, that pollen accounts for approximately 8.2% of adult ED visits near Austin, which is where the plants are most abundant. Further, the authors emphasize that various pollen remain in the air for most of the year in Texas, and this can create challenges for individuals who have asthma.2

“We ended up finding that some of the cities had these spikes in asthma-related ED visits in January, when that species releases its pollen, whereas cities outside its primary range did not have corresponding spikes,” said Katz in the news release.1

REFERENCES

1. Cornell University. Asthma emergencies spike when allergenic pollen blooms. News release. August 7, 2024. Accessed August 7, 2024. https://www.eurekalert.org/news-releases/1053905
2. Katz DSW, Zigler CM, Bhavnani D, Balcer-Whaley S, Matsui EC. Pollen and viruses contribute to spatio-temporal variation in asthma-related emergency department visits. Environ Res. 2024;257:119346. doi:10.1016/j.envres.2024.119346

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Austin Texas | Image credit: Kevin Ruck - stock.adobe.com
Pharmacy Times OPC
Related Content
Advertisement
Visualization of CAR T-cell among red blood cells | Image Credit: © Olha - stock.adobe.com
July 1st 2025

Cilta-Cel Spurs Remission Milestone—But Is It a Cure?

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Destruction of lymphoblasts. Conceptual 3D illustration of treatment of acute lymphoblastic leukemia - Image credit: Dr_Microbe | stock.adobe.com
July 1st 2025

ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes

Kennedy Ferruggia, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Visualization of pulmonary hypertension | Image Credit: © Thirawat - stock.adobe.com
June 30th 2025

Pulmonary Hypertension Associated With Increased Risk of Progression in Patients With Myeloproliferative Neoplasms

Alexandra Gerlach, Associate Editor
Illustration of bone marrow fibrosis | Image Credit: © AImmersive Imagery - stock.adobe.com
June 30th 2025

Ropeginterferon Alfa 2b Is Well-Tolerated, Efficacious in Treatment of Prefibrotic Myelofibrosis

Alexandra Gerlach, Associate Editor
Related Content
Advertisement
Visualization of CAR T-cell among red blood cells | Image Credit: © Olha - stock.adobe.com
July 1st 2025

Cilta-Cel Spurs Remission Milestone—But Is It a Cure?

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Destruction of lymphoblasts. Conceptual 3D illustration of treatment of acute lymphoblastic leukemia - Image credit: Dr_Microbe | stock.adobe.com
July 1st 2025

ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes

Kennedy Ferruggia, Assistant Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Visualization of pulmonary hypertension | Image Credit: © Thirawat - stock.adobe.com
June 30th 2025

Pulmonary Hypertension Associated With Increased Risk of Progression in Patients With Myeloproliferative Neoplasms

Alexandra Gerlach, Associate Editor
Illustration of bone marrow fibrosis | Image Credit: © AImmersive Imagery - stock.adobe.com
June 30th 2025

Ropeginterferon Alfa 2b Is Well-Tolerated, Efficacious in Treatment of Prefibrotic Myelofibrosis

Alexandra Gerlach, Associate Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.